Owlet, Inc. declined 2.55% in intraday trading, despite the company announcing the launch of its medically-certified Dream Sock™ in South Africa. The product, distributed as a Class C Medical Device with CE Marking, enables parents to track their baby's live vital signs and receive real-time health notifications.
Comments
No comments yet